Screener
EBITDA at other companies
Other financials
Where this comes from
Calculated from Apogee Therapeutics, Inc.’s reported figures.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
FAQ
- What is Apogee Therapeutics, Inc.'s EBITDA?
- Apogee Therapeutics, Inc. (APGE) reported EBITDA of -$82.36M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s EBITDA changed year-over-year?
- Apogee Therapeutics, Inc.'s EBITDA decreased by 31.0% year-over-year, from -$62.89M to -$82.36M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Apogee Therapeutics, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude